EDX Medical Group

EDX Medical Group FCF Margin

The Free Cash Flow Margin of EDX Medical Group (EDX.AQ) as of Nov 2, 2026 is -2,995.35 %. In the previous year, Free Cash Flow Margin was -1,400.22 % — a change of 113.92% (lower).

FCF Margin

-2,995.35 %

YoY

113.92%

Last updated:

Free Cash Flow Margin of EDX Medical Group is 2025 -2,995.35 % . Free Cash Flow Margin of EDX Medical Group was 2024 -1,400.22 % . It decreases by 113.92% lower compared to the previous year.

The EDX Medical Group FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2023
-32,779.49 GBP
Jan 1, 2024
-1,400.22 GBP
Jan 1, 2025
-2,995.35 GBP
The EDX Medical Group FCF Margin history
YEARFCF MarginYoY
-2,995.35 %+113.92%
-1,400.22 %-95.73%
-32,779.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EDX Medical Group Stock analysis

What does EDX Medical Group do? EDX Medical Group Plc generates revenue through the sale of digitally enabled diagnostic products and services to individuals and organizations. The company offers point-of-care, home, and workplace testing tools that allow personalized diagnosis according to international standards. Its disease surveillance solutions are sold to cross-border agencies and governments for identifying new disease variants with high transmission risks. The firm also partners with researchers and clinicians to commercialize their discoveries into marketable products. The primary buyers of EDX Medical Group's diagnostic tools include healthcare professionals, individuals seeking personal health monitoring, and government agencies responsible for public health surveillance. Cross-border agencies utilize the disease surveillance solutions to track rapidly spreading variants. Researchers and clinicians form strategic partnerships to develop and launch new diagnostic products through the company's platform. EDX Medical Group's product portfolio consists of diagnostic tests for point-of-care, home, and workplace use, alongside disease surveillance systems. The company's services focus on enabling personalized medical diagnosis and early detection of disease variants. Revenue streams are derived from direct sales of diagnostic tools, government contracts for surveillance systems, and partnership agreements with research institutions. EDX Medical Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EDX Medical Group stock

Free Cash Flow Margin of EDX Medical Group is -2,995.35 % in 2025.

Free Cash Flow Margin of EDX Medical Group changed from -1,400.22 % to -2,995.35 %, representing a 113.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin EDX Medical Group since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's EDX Medical Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — EDX Medical Group

All Key Metrics — EDX Medical Group